UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells

Cited by (109)

Items 101–109 of 109

1. Clonage et caractérisation des uridine diphospho-glucuronosyltransferases (UGT) effectuant la glucuronidation des hormones stéroïdiennes chez la souris
   Olivier Larouche · 2009
2. [Advances in medical therapy of hypertension].
   J.M.Romeo Orbegozo · 1953 · PubMed
3. Extreme Activation of Androgen Receptor for Prostate Cancer Therapy
   Mohammadreza Alizadeh‐Ghodsi · 2021 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
4. Androgen-Metabolic Genes in Prostate Cancer Predisposition and Progression
   Juergen K. V. Reichardt, Ann W. Hsing · 2009 · Springer eBooks
5. Data from Androgen-Stimulated UDP-Glucose Dehydrogenase Expression Limits Prostate Androgen Availability without Impacting Hyaluronan Levels
   Qin Wei, Robert Galbenus, Ashraf S. Raza, Ronald L. Cerny, Melanie A. Simpson · 2023
6. Data from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
   Sandra M. Lopez, Alexander I. Agoulnik, Manqi Zhang, Leif E. Peterson, Egla Suarez, Gregory A. Gandarillas, Anna Frolov, Rile Li, Kimal Rajapakshe, Christian Coarfa et al. · 2023
7. A novel lncRNA PROCA11 regulates cell plasticity in response to androgen deprivation of prostate cancer cells
   Rocco Cipolla, Marc Gabriel, Giorgia Ianese Regin, Micaela Piemontese, Ugo Szachnowski, Virginie Firlej, Marina Pinskaya, Antonin Morillon · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
8. Downregulation of UGT2B15 and UGT2B17 contributes to acquired androgen antagonist resistance in prostate cancer cells
   D. Alwyn Dart · 2024 · Academia oncology.
9. Role of long non-coding RNAs in prostate cancer progression
   Rocco Cipolla · 2023